Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-23

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for zolpidem tartrate from NorthStar Rx LLC under ANDA078413, enabling its continued marketing as a generic sleep ai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)